Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-07

Clinical Trial Update: A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis Subjects [Phase 4]

View source ↗

Summary

A Phase 4 trial update evaluating two assessment tools for predicting treatment success in rheumatoid arthritis patients treated with Cimzia (certolizumab pegol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CIMZIA (CERTOLIZUMAB PEGOL)

Snippet

Sponsor: UCB Pharma | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2014-03-07